Barron Aaron, Manna Samprikta, McElwain Colm J, Musumeci Andrea, McCarthy Fergus P, O'Keeffe Gerard W, McCarthy Cathal M
Department of Anatomy and Neuroscience, University College, Cork, Ireland.
Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland.
Front Physiol. 2023 Jan 12;13:1043481. doi: 10.3389/fphys.2022.1043481. eCollection 2022.
Pre-eclampsia (PE) is a common and serious hypertensive disorder of pregnancy, which affects 3%-5% of first-time pregnancies and is a leading cause of maternal and neonatal morbidity and mortality. Prenatal exposure to PE is associated with an increased risk of neurodevelopmental disorders in affected offspring, although the cellular and molecular basis of this increased risk is largely unknown. Here, we examined the effects of exposure to maternal serum from women with PE or a healthy uncomplicated pregnancy on the survival, neurite growth and mitochondrial function of neuronally differentiated human SH-SY5Y neuroblastoma cells, which are commonly used to study neurite growth. Neurite growth and mitochondrial function are two strongly linked neurodevelopmental parameters in which alterations have been implicated in neurodevelopmental disorders. Following this, we investigated the pleiotropic cytokine interleukin-6 (IL-6) levels as a potential mechanism. Cells exposed to 3% (v/v) PE serum for 72 h exhibited increased neurite growth ( < 0.05), which was validated in the human neural progenitor cell line, ReNcell VM ( < 0.01), and mitochondrial respiration (elevated oxygen consumption rate ( < 0.05), basal mitochondrial respiration, proton leak, ATP synthesis, and non-mitochondrial respiration) compared to control serum-treated cells. ELISA analysis showed elevations in maternal IL-6 in PE sera ( < 0.05) and placental explants ( < 0.05). In support of this, SH-SY5Y cells exposed to 3% (v/v) PE serum for 24 h had increased phospho-STAT3 levels, which is a key intracellular mediator of IL-6 signalling ( < 0.05). Furthermore, treatment with anti-IL-6 neutralizing antibody blocked the effects of PE serum on neurite growth ( < 0.05), and exposure to IL-6 promoted neurite growth in SH-SY5Y cells ( < 0.01). Collectively these data show elevated serum levels of maternal IL-6 in PE, which increases neurite growth and mitochondrial function in SH-SY5Y cells. This rationalizes the further study of IL-6 as a potential mediator between PE exposure and neurodevelopmental outcome in the offspring.
子痫前期(PE)是一种常见且严重的妊娠高血压疾病,影响3% - 5%的初产妇,是孕产妇和新生儿发病及死亡的主要原因。产前暴露于子痫前期会增加受影响后代患神经发育障碍的风险,尽管这种风险增加的细胞和分子基础在很大程度上尚不清楚。在此,我们研究了暴露于子痫前期女性或健康无并发症妊娠女性的母血清对神经分化的人SH - SY5Y神经母细胞瘤细胞(常用于研究神经突生长)的存活、神经突生长和线粒体功能的影响。神经突生长和线粒体功能是两个紧密相关的神经发育参数,其改变与神经发育障碍有关。在此之后,我们研究了多效细胞因子白细胞介素 - 6(IL - 6)水平作为一种潜在机制。与对照血清处理的细胞相比,暴露于3%(v/v)子痫前期血清72小时的细胞神经突生长增加(<0.05),这在人神经祖细胞系ReNcell VM中得到验证(<0.01),并且线粒体呼吸(氧消耗率升高(<0.05)、基础线粒体呼吸、质子泄漏、ATP合成和非线粒体呼吸)增强。ELISA分析显示子痫前期血清中母源IL - 6升高(<0.05),胎盘外植体中也升高(<0.05)。支持这一点的是,暴露于3%(v/v)子痫前期血清24小时的SH - SY5Y细胞磷酸化STAT3水平升高,STAT3是IL - 6信号传导的关键细胞内介质(<0.05)。此外,用抗IL - 6中和抗体处理可阻断子痫前期血清对神经突生长的影响(<0.05),而暴露于IL - 6可促进SH - SY5Y细胞的神经突生长(<0.01)。这些数据共同表明子痫前期母源血清中IL - 6水平升高,这增加了SH - SY5Y细胞的神经突生长和线粒体功能。这使得将IL - 6作为子痫前期暴露与后代神经发育结局之间潜在介质的进一步研究具有合理性。